|
1
|
Narayanan M, Gopi A, Natarajan D,
Kandasamy S, Saravanan M, El Askary A, Elfasakhany A and
Pugazhendhi A: Hepato and nephroprotective activity of methanol
extract of Hygrophila spinosa and its antibacterial
potential against multidrug resistant Pandoraea sputorum.
Environ Res. 201(111594)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Parasuraman S, Qi YZ and Jie LW: Hepato-
and nephroprotective effects of ethanolic extract of seeds of
Macrotyloma uniflorum on paracetamol-induced hepato- and
nephrotoxicity in rats. Indian J Pharm Educ Res. 56:772–779.
2022.
|
|
3
|
Li M, Xie F, Wang L, Zhu G, Qi LW and
Jiang S: Celastrol: An update on its hepatoprotective properties
and the linked molecular mechanisms. Front Pharmacol.
13(857956)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Alkandahri MY, Pamungkas BT, Oktoba Z,
Shafirany MZ, Sulastri L, Arfania M, Anggraeny EN, Pratiwi A,
Astuti FD, Indriyani , et al: Hepatoprotective effect of
kaempferol: A review of the dietary sources, bioavailability,
mechanisms of action, and safety. Adv Pharmacol Pharm Sci.
2023(1387665)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Iranshahy M, Iranshahi M, Abtahi SR and
Karimi G: The role of nuclear factor erythroid 2-related factor 2
in hepatoprotective activity of natural products: A review. Food
Chem Toxicol. 120:261–276. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Okokon JE, Udobang JA, Bassey AI, Edem UA
and Agu EC: Hepatoprotective and nephroprotective activities of
husk extract of Zea mays against paracetamol-induced liver
and kidney injuries in rats. Trop J Nat Prod Res. 4:67–76.
2020.
|
|
7
|
Abdel-Hady H, El-Sayed M, Abdel-hady AA,
Hashash MM, Abdel-Hady AM, Aboushousha T, Abdel-Hameed ES,
Abdel-Lateef EE and Morsi EA: Nephroprotective activity of
methanolic extract of Lantana camara and squash
(Cucurbita pepo) on cisplatin-induced nephrotoxicity in rats
and identification of certain chemical constituents of Lantana
camara by HPLC-ESI-MS. Pharmacogn J. 10:136–147. 2018.
|
|
8
|
Al-Snafi AE and Talab TA: A review of
medicinal plants with nephroprotective effects. GSC Biol Pharm Sci.
8:114–122. 2019.
|
|
9
|
Sujana D, Saptarini NM, Sumiwi SA and
Levita J: Nephroprotective activity of medicinal plants: A review
on in-silico, in-vitro, and in-vivo based studies. J Appl Pharm
Sci. 11:113–127. 2021.
|
|
10
|
Wannes WA and Tounsi MS: Tunisian
nephroprotective plants: A review. J Explor Res Pharmacol. 8:74–91.
2023.
|
|
11
|
Devarbhavi H, Asrani SK, Arab JP, Nartey
YA, Pose E and Kamath PS: Global burden of liver disease: 2023
update. J Hepatol. 79:516–537. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bello AK, Okpechi IG, Levin A, Ye F,
Damster S, Arruebo S, Donner JA, Caskey FJ, Cho Y, Davids MR, et
al: An update on the global disparities in kidney disease burden
and care across world countries and regions. Lancet Glob Health.
12:e382–e395. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
El-Rabey HA, Rezk SM, Sakran MI, Mohammed
GM, Bahattab O, Balgoon MJ, Elbakry MA and Bakry N: Green coffee
methanolic extract and silymarin protect against
CCl4-induced hepatotoxicity in albino male rats. BMC
Complement Med Ther. 21(19)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tienda-Vázquez MA, Morreeuw ZP,
Sosa-Hernández JE, Cardador-Martínez A, Sabath E, Melchor-Martínez
EM, Iqbal HMN and Parra-Saldívar R: Nephroprotective plants: A
review on the use in pre-renal and post-renal diseases. Plants
(Basel). 11(818)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lawson SK, Satyal P and Setzer WN: The
volatile phytochemistry of seven native american aromatic medicinal
plants. Plants (Basel). 10(1061)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Alkandahri MY, Maulana YE, Subarnas A,
Kwarteng A and Berbudi A: Antimalarial activity of extract and
fractions of Cayratia trifolia (L.) domin. Int J Pharm Res.
12:1435–1441. 2020.
|
|
17
|
Elfahmi , Woerdenbag HJ and Kayser
O: Jamu: Indonesian traditional herbal medicine towards rational
phytopharmacological use. J Herb Med. 4:51–73. 2014.
|
|
18
|
Farhamzah Kusumawati AH, Alkandahri MY,
Hidayah H, Sujana D, Gunarti NS, Yuniarsih N, Apriana SD and
Agustina LS: Sun protection factor activity of black glutinous rice
emulgel extract (Oryza sativa var glutinosa). Indian J Pharm
Educ Res. 56:302–310. 2022.
|
|
19
|
Salim E, Fatimah C and Fanny DY: Analgetic
activity of Cep-cepan (Saurauia cauliflora Dc.) leaves
extract. J Nat. 17:31–38. 2017.
|
|
20
|
Alkandahri MY, Berbudi A, Utami NV and
Subarnas A: Antimalarial activity of extract and fractions of
Castanopsis costata (Blume) A.DC. Avicenna J Phytomed.
9:474–481. 2019.PubMed/NCBI
|
|
21
|
Alkandahri MY, Sujana D, Hasyim DM,
Shafirany MZ, Sulastri L, Arfania M, Frianto D, Farhamzah
Kusumawati AH and Yuniarsih N: Antidiabetic activity of extract and
fractions of Castanopsis costata leaves on alloxan-induced
diabetic mice. Pharmacogn J. 13:1589–1593. 2021.
|
|
22
|
Alkandahri MY, Arfania M, Abriyani E,
Ridwanuloh D, Farhamzah F, Fikayuniar L, Hasyim DM and Nurul and
Wardani D: Evaluation of antioxidant and antipyretic effects of
ethanolic extract of cep-cepan leaves (Castanopsis costata
(Blume) A.DC). J Adv Pharm Educ Res. 12:107–112. 2022.
|
|
23
|
Alkandahri MY, Kusumiyati K, Renggana H,
Arfania M, Frianto D, Wahyuningsih ES and Maulana YE:
Antihyperlipidemic activity of extract and fractions of
Castanopsis costata leaves on rats fed with high cholesterol
diet. RASĀYAN J Chem. 15:2350–2358. 2022.
|
|
24
|
Alkandahri MY, Sholih MG, Fadilah NN,
Arfania M, Amal S, Frianto D, Mardiana LA, Astuti D and Hasyim DM:
Evaluation of antidiarrheal, antispasmodic, and antisecretory
activities of extract and fractions of Castanopsis costata
leaves in animal models. Pharmacogn J. 15:31–37. 2023.
|
|
25
|
Alkandahri MY, Sadino A, Pamungkas BT,
Oktoba Z, Arfania M, Yuniarsih N, Wahyuningsih ES and Putri DE:
Pharmacological evaluation of anti-inflammatory, antipyretic,
analgesic, and antioxidant activities of Castanopsis costata
leaf fractions (water, ethyl acetate, and n-hexane fractions): The
potential medicinal plants from North Sumatra, Indonesia. Res Pharm
Sci. 19:251–266. 2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ielciu I, Sevastre B, Olah NK, Turdean A,
Chișe E, Marica R, Oniga I, Uifălean A, Sevastre-Berghian AC,
Niculae M, et al: Evaluation of hepatoprotective activity and
oxidative stress reduction of Rosmarinus officinalis L.
shoots tincture in rats with experimentally induced hepatotoxicity.
Molecules. 26(1737)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Song X, Liu Z, Zhang J, Yang Q, Ren Z,
Zhang C, Liu M, Gao Z, Zhao H and Jia L: Anti-inflammatory and
hepatoprotective effects of exopolysaccharides isolated from
Pleurotus geesteranus on alcohol-induced liver injury. Sci
Rep. 8(10493)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang W, Liu H, Zhang Y, Feng Y, Yuan F,
Song X, Gao Z, Zhang J, Song Z and Jia L: Antihyperlipidemic and
hepatoprotective properties of alkali- and enzyme-extractable
polysaccharides by Dictyophora indusiata. Sci Rep.
9(14266)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wardani G, Nugraha J, Mustafa MR and
Sudjarwo SA: Antioxidative stress and anti-inflammatory activity of
fucoidan nanoparticles against nephropathy of
streptozotocin-induced diabetes in rats. Evid Based Complement
Alternat Med. 2022(3405871)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Perez-Meseguer J, Torres-González L,
Gutiérrez-González JA, Alarcón-Galván G, Zapata-Chavira H, Torres
NW, Moreno-Peña DP, Muñoz-Espinosa LE and Cordero-Pérez P:
Anti-inflammatory and nephroprotective activity of Juglans
mollis against renal ischemia-reperfusion damage in a wistar
rat model. BMC Complement Altern Med. 19(186)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Al-Harbi LN, Alshammari GM, Shamlan G,
Binobead MA, AlSedairy SA, Al-Nouri DM, Arzoo S and Yahya MA:
Nephroprotective and anti-diabetic potential of Beta
vulgaris L. Root (Beetroot) methanolic extract in a rat model
of type 2 diabetes mellitus. Medicina (Kaunas).
60(394)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hidayah H, Amal S, Yuniarsih N, Farhamzah
F, Kusumawati AH, Gunarti NS, Abriyani E, Mursal ILP, Sundara AK
and Alkandahri MY: Sun protection factor activity of Jamblang
leaves serum extract (Syzygium cumini). Pharmacogn J.
15:134–140. 2023.
|
|
33
|
Kiran PM, Raju AV and Rao BG:
Investigation of hepatoprotective activity of Cyathea
gigantea (Wall. ex. Hook.) leaves against paracetamol-induced
hepatotoxicity in rats. Asian Pac J Trop Biomed. 2:352–356.
2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zakaria ZA, Kamisan FH, Kek TL and Salleh
MZ: Hepatoprotective and antioxidant activities of Dicranopteris
linearis leaf extract against paracetamol-induced liver
intoxication in rats. Pharm Biol. 58:478–489. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Okokon JE, Simeon JO and Umoh EE:
Hepatoprotective activity of the extract of Homalium
letestui stem against paracetamol-induced liver injury.
Avicenna J Phytomed. 7:27–36. 2017.PubMed/NCBI
|
|
36
|
Dewi IP, Aldiana M, Viadina ZA, Fajrin FA,
Holidah D and Christianty FM: Nephroprotective effect of sugarcane
(Saccharum officinarum L.) leaves ethanol extract on
gentamicin-induced nephrotoxicity in rats. J Adv Pharm Technol Res.
15:208–213. 2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Iqbal SM, Hussain L, Hussain M, Akram H,
Asif M, Jamshed A, Saleem A and Siddique R: Nephroprotective
potential of a standardized extract of Bambusa arundinacea:
In vitro and in vivo studies. ACS Omega. 7:18159–18167.
2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Foghis M, Tit DM, Bungau SG, Ghitea TC,
Pallag CR, Foghis AM, Behl T, Bustea C and Pallag A: Highlighting
the use of the hepatoprotective nutritional supplements among
patients with chronic diseases. Healthcare (Basel).
11(2685)2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Basist P, Parveen B, Zahiruddin S, Gautam
G, Parveen R, Khan MA, Krishnan A, Shahid M and Ahmad S: Potential
nephroprotective phytochemicals: Mechanism and future prospects. J
Ethnopharmacol. 283(114743)2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hosack T, Damry D and Biswas S:
Drug-induced liver injury: A comprehensive review. Therap Adv
Gastroenterol. 16(17562848231163410)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Perazella MA and Rosner MH: Drug-induced
acute kidney injury. Clin J Am Soc Nephrol. 17:1220–1233.
2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU,
Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, et al: KASL clinical
practice guidelines: Management of nonalcoholic fatty liver
disease. Clin Mol Hepatol. 27:363–401. 2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Japanese Society of Nephrology. Essential
points from evidence-based clinical practice guideline for chronic
kidney disease 2023. Clin Exp Nephrol. 28:473–495. 2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Meharie BG, Amare GG and Belayneh YM:
Evaluation of hepatoprotective activity of the crude extract and
solvent fractions of Clutia abyssinica (Euphorbiaceae) leaf
against CCl4-induced hepatotoxicity in mice. J Exp
Pharmacol. 12:137–150. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pandey B, Baral R, Kaundinnyayana A and
Panta S: Promising hepatoprotective agents from the natural
sources: A study of scientific evidence. Egypt Liver J.
13(14)2023.
|
|
46
|
Molaei E, Molaei A, Abedi F, Hayes AW and
Karimi G: Nephroprotective activity of natural products against
chemical toxicants: The role of Nrf2/ARE signaling pathway. Food
Sci Nutr. 9:3362–3384. 2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chidiac AS, Buckley NA, Noghrehchi F and
Cairns R: Paracetamol (acetaminophen) overdose and hepatotoxicity:
Mechanism, treatment, prevention measures, and estimates of burden
of disease. Expert Opin Drug Metab Toxicol. 19:297–317.
2023.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Oh RC, Hustead TR, Ali SM and Pantsari MW:
Mildly elevated liver transaminase levels: Causes and evaluation.
Am Fam Physician. 96:709–715. 2017.PubMed/NCBI
|
|
49
|
Giannini EG, Testa R and Savarino V: Liver
enzyme alteration: A guide for clinicians. CMAJ. 172:367–379.
2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Nkosi CZ, Opoku AR and Terblanche SE:
Effect of pumpkin seed (Cucurbita pepo) protein isolate on
the activity levels of certain plasma enzymes in
CCl4-induced liver injury in low-protein fed rats.
Phytother Res. 19:341–345. 2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ruiz ARG, Crespo J, Martínez RML,
Iruzubieta P, Mercadal GC, Garcés ML, Lavin B and Ruiz MM:
Measurement and clinical usefulness of bilirubin in liver disease.
Adv Lab Med. 2:352–372. 2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Arguello G, Balboa E, Arrese M and
Zanlungo S: Recent insights on the role of cholesterol in
non-alcoholic fatty liver disease. Biochim Biophys Acta.
1852:1765–1778. 2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Maretti-Mira AC, Salomon MP, Hsu AM, Kanel
GC and Golden-Mason L: Hepatic damage caused by long-term high
cholesterol intake induces a dysfunctional restorative macrophage
population in experimental NASH. Front Immunol.
13(968366)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wang X, Wu Q, Liu A, Anadón A, Rodríguez
JL, Martínez-Larrañaga MR, Yuan Z and Martínez MA: Paracetamol:
Overdose-induced oxidative stress toxicity, metabolism, and
protective effects of various compounds in vivo and in vitro. Drug
Metab Rev. 49:395–437. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Khademalhosseini M, Ranjbar E, Mohammadi
R, Khalili P, Mehran M, Jalali N, Rajabi Z and Jamali Z: Dietary
antioxidants and liver enzymes in Rafsanjan, a region in Southeast
Iran. Sci Rep. 13(8555)2023.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Gillessen A and Schmidt HHJ: Silymarin as
supportive treatment in liver diseases: A narrative review. Adv
Ther. 37:1279–1301. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Karimi G, Vahabzadeh M, Lari P, Rashedinia
M and Moshiri M: ‘Silymarin’, a promising pharmacological agent for
treatment of diseases. Iran J Basic Med Sci. 14:308–317.
2011.PubMed/NCBI
|
|
58
|
Akhtar MN, Saeed R, Saeed F, Asghar A,
Ghani S, Ateeq H, Ahmed A, Rasheed A, Afzaal M, Waheed M, et al:
Silymarin: A review on paving the way towards promising
pharmacological agent. Int J Food Prop. 26:2256–2272. 2023.
|
|
59
|
Balakumar P, Rohilla A and
Thangathirupathi A: Gentamicin-induced nephrotoxicity: Do we have a
promising therapeutic approach to blunt it? Pharmacol Res.
62:179–186. 2010.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Tesfa E, Munshea A, Nibret E, Mekonnen D,
Sinishaw MA and Gizaw ST: Maternal serum uric acid, creatinine and
blood urea levels in the prediction of pre-eclampsia among pregnant
women attending ANC and delivery services at Bahir Dar city public
hospitals, northwest Ethiopia: A case-control study. Heliyon.
8(e11098)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Chen L, Zhu Z, Ye S and Zheng M: The serum
uric acid to serum creatinine ratio is an independent risk factor
for diabetic kidney disease. Diabetes Metab Syndr Obes.
15:3693–3703. 2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Bustos PS, Deza-Ponzio R, Páez PL, Cabrera
JL, Virgolini MB and Ortega MG: Flavonoids as protective agents
against oxidative stress induced by gentamicin in systemic
circulation. Potent protective activity and microbial synergism of
luteolin. Food Chem Toxicol. 118:294–302. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Karimi Z, Pakfetrat Z, Roozbeh J and
Janfeshan S: Toll-like receptor-2 mediates systemic inflammation in
gentamicin-induced rat nephrotoxicity. Clin Exp Pharmacol Physiol.
47:1584–1590. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Faul F, Erdfelder E, Lang AG and Buchner
A: G*Power 3: A flexible statistical power analysis
program for the social, behavioral, and biomedical sciences. Behav
Res Methods. 39:175–191. 2007.PubMed/NCBI View Article : Google Scholar
|
